The AHA COVID-19 CVD Registry successfully enrolled over 4,000 hospitalized adult patients with active COVID-19 across more than 130 sites within 9 weeks of launch.
Observational (n=4,000)
Yes
The AHA COVID-19 CVD Registry was rapidly developed to collect data on hospitalized COVID-19 patients to evaluate outcomes and inform best practices.
BACKGROUND: In response to the public health emergency created by the coronavirus disease 2019 (COVID-19) pandemic, American Heart Association volunteers and staff aimed to rapidly develop and launch a resource for the medical and research community to expedite scientific advancement through shared learning, quality improvement, and research. In 130 sites have enrolled in the program and >4000 records have been abstracted in the national dataset. Additionally, the aggregate dataset will be a valuable data resource for the medical research community. CONCLUSIONS: The AHA COVID-19 CVD Registry will support greater understanding of the impact of COVID-19 on cardiovascular disease and will inform best practices for evaluation and management of patients with COVID-19.
Alger et al. (Wed,) conducted a observational in COVID-19 (n=4,000). COVID-19 infection was evaluated. The AHA COVID-19 CVD Registry successfully enrolled over 4,000 hospitalized adult patients with active COVID-19 across more than 130 sites within 9 weeks of launch.